Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML

Chemoresistance poses a significant impediment to effective treatment strategies for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Our previous study unveiled that oncogene TWIST1 interacted with DNA methyltransferase 3a (DNMT3a) to regulate the decitabine (DAC) resistance in MDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongjiao, Wang, Yi, Feng, Shuang, Chang, Kaijing, Yu, Xinwen, Yang, Fenfang, Huang, Haozhe, Wang, Yuanbo, Li, Xiang, Guan, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514931/
https://www.ncbi.nlm.nih.gov/pubmed/37736724
http://dx.doi.org/10.1186/s12964-023-01278-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514931/
https://www.ncbi.nlm.nih.gov/pubmed/37736724
http://dx.doi.org/10.1186/s12964-023-01278-y

Ejemplares similares